Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (121-130 of 354) with videos related to

Pageof 36
Sort By:
Neurosurgery|August 4, 2010
Endoscopic endonasal minimal access approach to the clivus: case series and technical nuancesJustin F Fraser, Gurston G Nyquist, Nicholas Moore, et al.
Journal of Analytical Toxicology|June 9, 2007
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole bloodKarine Titier, Nadège Castaing, Maité Le-Déodic, et al.
International Journal of Surgical Pathology|October 12, 2019
Mycobacterium Spindle Cell Pseudotumor Caused by <i>Mycobacterium xenopi</i>: A First Described Association of a Rare Entity Presenting in the LungKarina Furlan, Prih Rohra, Fatima Mir, et al.
Current Medical Research and Opinion|March 31, 2022
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tabletsHelmut Butzkueven, Nicholas Moore, Aida Aydemir, et al.
Clinical Pharmacology and Therapeutics|September 7, 2017
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life SettingJulien Bezin, Olaf H Klungel, Régis Lassalle, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2008
Prevalence of cholinesterase inhibitors in subjects with dementia in EuropeAntoine Pariente, Catherine Helmer, Yvon Merliere, et al.
Schizophrenia Research|September 12, 2002
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patientsChristine Montout, Francoise Casadebaig, Rajaa Lagnaoui, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2018
Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM studySinem Ezgi Gulmez, Ulku Sur Unal, Régis Lassalle, et al.
Cardiovascular Drugs and Therapy|April 30, 2004
Fluvastatin reduces cardiac mortality in patients with coronary heart diseaseChristie M Ballantyne, Günter Riegger, Nicholas Moore, et al.
Acta Ophthalmologica|August 4, 2017
The effects of antioxidants on ocular blood flow in patients with glaucomaAlon Harris, Josh Gross, Nicholas Moore, et al.
Pageof 36

Showing results (121-130 of 354) with videos related to

Sort By:
Pageof 36
Neurosurgery|August 4, 2010
Endoscopic endonasal minimal access approach to the clivus: case series and technical nuancesJustin F Fraser, Gurston G Nyquist, Nicholas Moore, et al.
Journal of Analytical Toxicology|June 9, 2007
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole bloodKarine Titier, Nadège Castaing, Maité Le-Déodic, et al.
International Journal of Surgical Pathology|October 12, 2019
Mycobacterium Spindle Cell Pseudotumor Caused by <i>Mycobacterium xenopi</i>: A First Described Association of a Rare Entity Presenting in the LungKarina Furlan, Prih Rohra, Fatima Mir, et al.
Current Medical Research and Opinion|March 31, 2022
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tabletsHelmut Butzkueven, Nicholas Moore, Aida Aydemir, et al.
Clinical Pharmacology and Therapeutics|September 7, 2017
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life SettingJulien Bezin, Olaf H Klungel, Régis Lassalle, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2008
Prevalence of cholinesterase inhibitors in subjects with dementia in EuropeAntoine Pariente, Catherine Helmer, Yvon Merliere, et al.
Schizophrenia Research|September 12, 2002
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patientsChristine Montout, Francoise Casadebaig, Rajaa Lagnaoui, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2018
Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM studySinem Ezgi Gulmez, Ulku Sur Unal, Régis Lassalle, et al.
Cardiovascular Drugs and Therapy|April 30, 2004
Fluvastatin reduces cardiac mortality in patients with coronary heart diseaseChristie M Ballantyne, Günter Riegger, Nicholas Moore, et al.
Acta Ophthalmologica|August 4, 2017
The effects of antioxidants on ocular blood flow in patients with glaucomaAlon Harris, Josh Gross, Nicholas Moore, et al.
Pageof 36